Conference Coverage
Conference Coverage
Eptinezumab Inhibitor Fails Cluster Headache Test
Failed primary but successful secondary measures hints that it might be time for a change in cluster headache clinical trial endpoints.
Conference Coverage
New Insight Into CVD, Stroke Risk in Migraine
Understanding how migraine relates to comorbid cardiovascular conditions is important because major adverse cerebrovascular events can be life-...
Conference Coverage
Are Primary Care Physicians the Answer to the US Headache Neurologist Shortage?
The American Headache Society developed the First Contact program with the aim of improving headache education in primary care and help alleviate...
Conference Coverage
Migraine Linked to Cardiovascular Risk in Veterans Study
A Veterans Administration study of migraine found a greater risk of stroke and TIA and a reduced risk of hemorrhagic stroke in men.
Conference Coverage
New Survey Explores New Daily Persistent Headache
Patient responses suggest CGRP inhibitors might be a good preventative, and that many experience brain fog.
Conference Coverage
Why Don’t Migraine Patients Seek Treatment?
Participants cited concerns that their complaints would be dismissed, a belief that healthcare providers could offer no additional help, and a...
Conference Coverage
Lidocaine Effective Against Pediatric Migraine
The first randomized, controlled trial confirms observational studies and could pave the way for insurance coverage.
Conference Coverage
Potential Genes Identified for Post-Traumatic Headache
Findings could point the way to screening youth for vulnerability to head trauma.
Conference Coverage
Measuring Cognition in Migraine, One Patient at a Time
Researchers are developing intensive testing methods to better understand cognitive function in different migraine phases.
Conference Coverage
Lidocaine Nerve Block Effective for Severe, Refractory Migraine in Children
“This is the first randomized controlled trial that shows lidocaine injections can be significantly more effective than a placebo for these...